Zeroing in on Dopamine
Study in mice identifies the molecular machinery responsible for dopamine release in the brain
Studied for decades for its critical role in movement control and reward-seeking behaviors, the neurotransmitter dopamine has been the focus of numerous efforts to understand its activity, particularly when it goes awry in disorders such as Parkinson’s and addiction.
While researchers have made great strides, less is known about the mechanisms that healthy dopamine cells use to release the neurotransmitter, a gap that has limited scientists’ ability to develop treatments for a range of dopamine-related conditions.
Now, researchers from Harvard Medical School have for the first time identified the molecular machinery responsible for the precise secretion of dopamine in the brain.
Click here to read more.
13th Annual International Symposium on Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery
Feb. 21-23, 2020; Lake Buena Vista, Fla.
2020 Winter Clinics for Cranial & Spinal Surgery
Feb. 23-27, 2020; Snowmass Village, Colo.
71st Annual Meeting of the Southern Neurosurgical Society
Feb. 26-29, 2020; Richmond, Va.
3rd Annual Mayo Clinic Advances and Innovations in Complex Neuroscience Patient Care: Brain and Spine 2020
Feb. 27-29, 2020; Sedona, Ariz.
Multidisciplinary Neuro-Oncology Symposium: Updates in Medical and Surgical Management of Brain Tumors
March 6-7, 2020; Orlando, Fla.